HALOZYME THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • Halozyme Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 127M shares, a 3.5% decline year-over-year.
  • Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 132M shares, a 3.59% decline from 2022.
  • Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 137M shares, a 2.7% decline from 2021.
  • Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 141M shares, a 3.26% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 127M -4.61M -3.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 127M -8.09M -5.99% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 132M -4.92M -3.59% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 132M -4.56M -3.34% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 132M -6.21M -4.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 135M -2.63M -1.91% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 137M -3.8M -2.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 137M -5.49M -3.87% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 138M -4.55M -3.19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 138M -294K -0.21% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 141M +5.54M +4.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 142M +5.44M +3.99% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 142M +6.55M +4.82% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 138M +766K +0.56% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 135M -5.94M -4.21% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-23
Q3 2020 137M -9.56M -6.54% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 136M -9.48M -6.52% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 137M -7.56M -5.22% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 141M -3.16M -2.19% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 146M +2.19M +1.52% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-23
Q2 2019 145M +1.84M +1.28% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-23
Q1 2019 145M +2.09M +1.46% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-23
Q4 2018 144M +2.49M +1.75% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-24
Q3 2018 144M +2.76M +1.95% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-24
Q2 2018 144M +9.56M +7.13% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 143M +14M +10.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-24
Q4 2017 142M +14.5M +11.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 141M +13M +10.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-21
Q2 2017 134M +6.06M +4.73% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-21
Q1 2017 129M +1M +0.78% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-21
Q4 2016 127M 0 0% Oct 1, 2016 Dec 31, 2016 10-K 2017-02-28
Q3 2016 128M +1.23M +0.97% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 128M +1.81M +1.44% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 128M +2.32M +1.85% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 127M Oct 1, 2015 Dec 31, 2015 10-K 2016-02-29
Q3 2015 127M +2.88M +2.32% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 126M +2.43M +1.97% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 125M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 124M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 124M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q3 2012 112M +9.08M +8.8% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 112M +9.39M +9.15% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-09
Q4 2011 103M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 103M +9.6M +10.3% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-01
Q2 2011 103M +10.9M +11.9% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-01
Q1 2011 101M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-01
Q3 2010 93.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 91.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.